ENG

ENG简体中文日本語한국어

  • Cindy GUO

    Equity Partner / Shanghai

  • Tel +86-21-6061-3584

    Email guowen@zhonglun.com

  • Practices

    Investment/M&A & Corporate Governance, Private Equity & Investment Funds, Hong Kong & Overseas Capital Markets

CV

Cindy GUO

Cindy Guo has substantial experience in the areas of M&A, PE investment, outbound direct investment, and foreign direct investment. She has advised various large multinational corporate clients (including 3M, Coca-Cola, Mycronic, ALS, Fullshare, IPCO, Linde, Marubeni, Shinho Group, and Driscoll's) on their business operation and transactional projects and a wide range of leading private equity funds and investment banks (including Goldman Sachs, GLP, CDH, Arsenal Capital, and SIGVC) on their equity investment projects. Her expertise has also extended to Chinese clients' cross-border transactions involving the U.S., UK, Sweden, Germany, South Korea, Japan, Vietnam, and other jurisdictions.

Cindy's profile is particularly distinguished by her work in buzzing industries such as high-end manufacturing, biopharma, and new energy vehicle. She has also assisted a number of companies in designing and implementing various types of equity incentive plans, including those for employees of overseas subsidiaries of domestic companies devised on the strength of her years of experience in foreign investment services.

In addition, Cindy had been worked as seconded in-house counsel for 3M to handle legal affairs of their Chinese business in healthcare and automotive industry.

Representative Matters

M&A

  • Advised IPCO AB, a global leading industrial process solutions company, on its acquisition of Longwin New Material

  • Advised shareholders of a well-known hearing aid retailer, Chengting Group, in their sale of the hearing aid retail business to Sonova, a Swiss listed company

  • Advised ALS, an Australian listed company, on its sale of a Chinese environmental inspection company to Suez Group, a French listed company

  • Advised ALS UK on the acquisition of equity interest in an inspection and test company held by its joint venture partner

  • Advised Mycronic AB, a Sweden listed company, on its acquisition of Axxon, a leading company in SMT industry, establishment of a joint venture, and its acquisition of the remaining equity

  • Advised Mycronic AB, a Sweden listed company, on its acquisition of majority ownership in Huan Cheng Xin, a leading company in SMT industry, and establishment of a joint venture

  • Advised Mycronic AB, a Sweden listed company, on its acquisition of ATG Group from Cohu, a Nasdaq-listed company

  • Advised well-known domestic fund New Value Fund on its acquisition of EIC Education from CVC

  • Advised a Hong Kong listed company Fullshare Holdings on its acquisition of real estate projects

  • Advised leading logistic company GLP on its acquisition of various logistics properties

  • Advised Logos Property on its acquisition of logistics property

  • Advised Shanying Intl, a Chinese A-share listed company, on its acquisition of a Sweden Company, Nordic Paper

  • Advised a US listed company, 3M, on its acquisition of an orthotics company

  • Advised a state-owned fund on its acquisition of a South Korean semiconductor company

  • Advised a Hong Kong listed company on its acquisition of assets (including real estate, trust companies, and third party payment licenses) of an A-share listed company

  • Advised a Hong Kong-listed company on its acquisition of a leading UK shopping mall and assets in the education sector


Investment and financing

  • Advised AVATR, a high-end electric vehicle company, on several rounds of its financing

  • Advised ReLive Biotechnologies Ltd. on its Series A financing

  • Advised Goldman Sachs on its investment in Burger King

  • Advised a well-known government guided fund on its investment in a large bankruptcy restructuring project and high-end equipment manufacturing enterprises

  • Advised a Hong Kong listed company on its investment in a new energy vehicle company

  • Advised Wanxiang Auto, a high-tech company, on its financing project

  • Advised the founding team of a game company, Gamepoch, on its financing project

  • Advised a Stanford 4C purification technology team on its financing project

  • Advised CDH on its investment in I-Mab, a domestically leading biotechnology company

  • Advised a Singaporean fund on its investment in a Stanford medical device incubation team

  • Advised a medical group founding team on its financing project

  • Advised a Hangzhou-based company specialized in new drug and diagnostic reagent on its financing project 

  • Advised a big data center on its financing project

  • Advised a US augmented reality technology company on its financing project

  • Advised a well-known fund on its investment in a Chinese futures company

  • Advised a Hong Kong listed company on its investment in a well-known domestic hotel group

  • Advised an incubation team of Arizona State University on its financing project

Honors and Awards

For Individual

ALB China Client Choice, Asian Legal Business, 2025

Rising Stars 2022, China Business Law Journal, 2022

Next Generation Lawyers, Legal 500, 2017

Publications

Foreign Investment in Micro-Credit Companies in China, China Business Law Journal, April 2011

Related

  • Bar Admissions/Professional Qualifications

    PRC Bar, 2011

  • Education

    LL.M., University College London, 2008
    LL.B., Anhui University, 2007

  • Professional Experience

    Partner, non-equity partner, and associate, Zhong Lun Law Firm , 2014 - 2019
    Associate, Martin Hu & Partners, 2009 - 2014

  • Languages

    Chinese
    English